US visitors, please note: This website contains information on the PROGENSA® PCA3 Assay which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or applicable in the USA. View details on US FDA approval for PROGENSA® PCA3 Assay.
Traitement supplémentaire (souvent hormonal) administré avant le traitement primaire (radiothérapie ou prostatectomie radicale) afin d’augmenter l’effet du traitement/les chances de guérison.